Filtration & fluid control
Blood, sweat and tears F
iltration technologies have come a long way. Classically, they have been used mostly for sterilisation where micro-organisms are separated from the rest of the medium, leaving a sterile solution behind. They feature in other industrial processes too, from water desalination to bioprocessing. Increasingly, though, the medical device industry is applying filtration at smaller scales for advanced monitoring and diagnostic applications.
At its most basic level, filtration involves separating solid particles from a liquid or gas, via some kind of physical barrier or membrane. Smaller particles, like water molecules, can pass through the pores in this barrier, whereas larger particles like microbes cannot.
This simple principle, which every secondary school pupil could describe, becomes ‘microfiltration’ when the particles are very small
62
(around 0.1–10μm), and ‘ultrafiltration’ when the separated species are much smaller still, typically in the 0.001–0.1μm range. Here, we are getting into the realm of microfluidics – the science of manipulating fluids on microscopic scales. “A microfluidic system works by precisely controlling and manipulating small fluid volumes,” explains Dr Taleieh Rajabi, a professor in the field of microfluidics and applied physics at RheinMain University of Applied Sciences, and head of precision microfluidics at a contract research organisation (CRO). “This enables continuous monitoring of health parameters; electrochemical sensors for real-time analysis of biofluids; and data transmission to smartphones or cloud platforms for further analysis and monitoring.”
Microfluidic platforms, often referred to as a ‘lab on a chip’, contain intricate networks of channels, chambers and control mechanisms. A fluid sample
www.medicaldevice-developments.com
Filtration is evolving beyond classical sterilisation and physical barrier function to support a range of emerging applications on microscopic scales. Abi Millar discusses how it is being used in liquid biopsy and in continuous-sampling wearable devices with Professor Taleieh Rajabi of RheinMain University of Applied Sciences.
Generative AI
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100